New Treatments for Pulmonary Arterial Hypertension

This publication has 99 references indexed in Scilit:

• Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
  The Lancet, 2001
• A new era in the treatment of primary pulmonary hypertension
  Heart, 2001
• Endothelins and Endothelin Receptor Antagonists
  Circulation, 2000
• Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor‐κB activation in J774 macrophages
  FEBS Letters, 1998
• Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension
  New England Journal of Medicine, 1998
• Vascular Endothelial Growth Factor in Pulmonary Hypertension
  Annals of the New York Academy of Sciences, 1996
• Short-term hemodynamic effect of a new oral PGI2 analogue, Beraprost, in primary and secondary pulmonary hypertension
  The American Journal of Cardiology, 1996
• How Effective Is the Treatment with High-Dose Nifedipine for Primary Pulmonary Hypertension?
  Seminars in Respiratory and Critical Care Medicine, 1994
• Plexiform Lesions in Primary Pulmonary Hypertension May Represent an Abnormal Form of Angiogenesis
  Seminars in Respiratory and Critical Care Medicine, 1994
• Iloprost
  Drugs, 1992